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Abstract 1 
 2 
Leptin, a pleiotropic hormone regulating food intake and metabolism, plays an 3 
important role in the regulation of inflammation and immunity. We previously 4 
demonstrated that serum leptin levels are profoundly increased in mice which received 5 
azoxymethane (AOM) and dextran sulfate sodium (DSS) as tumor-initiator and 6 
-promoter, respectively, in a colon carcinogenesis model. In this study, we attempted to 7 
address underlying mechanism whereby leptin is up-regulated in this rodent model. 8 
Five-week-old male ICR mice were given a single intraperitoneal injection of AOM 9 
(week 0), followed by 1% DSS in drinking water for 7 days. Thereafter, the weights of 10 
visceral fats and the serum concentration of leptin were determined at week 20. Of 11 
interest, the relative epididymal fat pad and mesenteric fat weights, together with serum 12 
leptin levels in the AOM and/or DSS-treated mice were markedly increased compared 13 
to that in untreated mice. In addition, leptin protein production in epididymal fat pad 14 
with AOM/DSS-treated mice was 4.7-fold higher than that of control. Further, insulin 15 
signaling molecules, such as protein kinase B (Akt), S6, mitogen-activate protein 16 
kinase/ extracellular signaling-regulated kinase 1/2, and extracellular signaling- 17 
regulated kinase 1/2, were concomitantly activated in epididymal fat of AOM/DSS- 18 
treated mice. This treatment also increased the serum insulin and IGF-1 levels. Taken 19 
together, our results suggest that higher levels of serum insulin and IGF-1 promote the 20 
insulin signaling in epididymal fat and thereby increasing serum leptin, which may play 21 
an crucial role in, not only obesity-related, but also -independent colon carcinogenesis. 22 
 23 
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Introduction 1 
 2 
Leptin, a 16-kDa protein encoded by the ob gene, was discovered in 1994 and 3 
shown to be a regulator of body weight and energy balance, functioning in the 4 
hypothalamus [1]. Although this hormone is produced mainly by WAT, its expression 5 
has also been detected in other tissues, including the gastrointestinal tract [2]. In humans, 6 
leptin levels are proportional to body mass index and are elevated in obese individuals 7 
[3]. Since obesity is known to increase the risk of certain cancers, great effort has been 8 
directed to elucidating the possible role of leptin in cancer development [4], and several 9 
in vitro studies showed that leptin can act as a mitogenic, anti-apoptotic, and 10 
tumorigenic factor with various cancer cell lines [5-7]. In addition, data obtained with 11 
clinical samples revealed that leptin and its receptor (Ob-R) are expressed in cancer 12 
tissues [8]. Thus, the leptin system might promote cancer progression in an autocrine 13 
and paracrine manner.  14 
   Our previous investigation demonstrated that serum leptin levels were profoundly 15 
increased in male ICR mice that received azoxymethane (AOM) and dextran sulfate 16 
sodium (DSS) for colitis-related colon carcinogenesis [9]. In addition, a citrus flavonoid, 17 
nobiletin, reduced not only those levels, but also colonic tumor development, whereas 18 
did not cause significant alterationsin serum levels of other adipocytokines (TNF-α, 19 
IL-6, and adiponectin) and triglyceride [9]. These findings led us to address and 20 
investigate an issue why and how serum leptin level is elevated in the mice treated with 21 
AOM and DSS in a colitis-related colon carcinogenesis model.  22 
   23 
Materials and Methods 24 
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 1 
Animals and chemicals 2 
Male Crj:CD-1 (ICR) mice (Japan SLC, Shizuoka, Japan) aged 5 weeks were 3 
obtained for this study. The animals were handled according to the Guidelines for the 4 
Regulation of Animals provided by the Experimentation Committee of Kyoto 5 
University and the experimental protocol was approved by the Committee. Upon arrival, 6 
all mice were randomized and transferred to plastic cages (5 mice/cage), with free 7 
access to drinking water and a pelleted basal diet MF diet (Oriental Yeast, Kyoto, Japan), 8 
and controlled conditions of humidity (60 ± 5%), light (12/12-hour light/dark cycle) and 9 
temperature (24 ± 2°C). All mice were quarantined for 1 week before starting the 10 
experiments.  11 
The colonic carcinogen AOM was purchased from Sigma Chemical Co. (St. Louis, 12 
MO). DSS with a molecular weight of 36,000 to 50,000 (Cat. No. 160110) was 13 
purchased from the MP Biochemicals, LLC (Aurora, OH) and used for induction of 14 
colitis, after being dissolved in distilled water to a concentration of 1% (w/v).  15 
 16 
Antibodies 17 
Antibodies directed against phospho-protein kinase B (Akt) (Ser483), phospho-S6 18 
(Ser240/244), phospho-mitogen-activate protein kinase/ extracellular 19 
signaling-regulated kinase (MEK)1/2 (Ser217/221) and phospho- extracellular 20 
signaling-regulated kinase (ERK)1/2 (Thr202/Tyr204), as well as horseradish 21 
peroxidase (HRP)-conjugated anti-rabbit antibody were obtained from Cell Signaling 22 
Technology (Beverly, MA).  23 
 24 
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Animal treatment 1 
A total of 80 male ICR mice were divided into four (3 experimental and 1 control) 2 
groups. Group 1 served as an untreated control. Mice in groups 2 and 4 were given a 3 
single i.p. injection of AOM (10 mg/kg body weight), then starting 1 week after that 4 
injection, those in group 4 received 1% DSS in drinking water for 7 days. Mice on 5 
group 3 received DSS alone according to the same time schedule. All groups were fed 6 
the basal diet throughout the study. At the end of weeks 2, 5 mice from each group were 7 
euthanized, then 15 mice from each group were euthanized after week 20. Euthanasia 8 
was performed under ether anesthesia, then blood samples were collected from the 9 
abdominal aorta. During the study, body weights of all animals were weighted weekly. 10 
At sacrifice, all organs, including adipose tissue, were removed and weighted, and then 11 
obtained adipose tissues were frozen using liquid nitrogen, until later use.  12 
 13 
Reverse transcription-polymerase chain reaction (RT-PCR) 14 
   Total RNA was extracted from the epididymal fat pads using TRIzol reagent 15 
(Invitrogen, Carlsbad, CA), according to the manufacturer’s instructions. cDNA was 16 
synthesized using 1 µg of total RNA with an RNA PCR Kit (AMV). PCR amplification 17 
was performed using a thermal cycler (PTC-100TM, MJ Research, Watertown, MA) 18 
and conducted with each sense and antisense primer, with GAPDH used as the internal 19 
standard. The primers for leptin were 5’-CCAAAACCCTCATCAAGACC-3’ and 5’- 20 
GTCCAACTGTTGAAGAATGTCCC-3’ (Proligo, Kyoto, Japan), which yielded an 21 
expected band size of 395 bp, while those for GAPDH were 5’-GTGAAGGTCGGA- 22 
GTCAACG-3’ and 5’-GGTGAAGACGCCAGTGGACTC-3’ (Proligo), which yielded 23 
an expected band size of 300 bp. The primers were used at final concentrations of 0.5 24 
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and 0.05 µM respectively. PCR was performed under the following conditions: 43 1 
cycles at 95ºC for 45 seconds, 57ºC for 45 seconds, and 72ºC for 45 seconds for leptin, 2 
and 27 cycles at 94ºC for 30 seconds, 55ºC for 30 seconds, and 72ºC for 30 seconds for 3 
GAPDH. The PCR products were subjected to electrophoresis on 3% agarose gels and 4 
stained with SYBR○R Gold. The intensity of each band was analyzed using Scion 5 
Image. 6 
 7 
Western blotting 8 
To determine the protein expressions of phospho-Akt, phospho-S6, 9 
phospho-MEK1/2, and phospho-ERK1/2 in the epididymal fat pads, tissue supernatants 10 
were subjected to Western blotting. Frozen adipose tissue was lysed in lysis buffer [10 11 
nM Tris, pH 7.4, 1% sodium dodecyl sulfate (SDS), 1 mM sodium metavanadate (V)], 12 
and centrifuged at 3200 x g for 5 minutes. Denatured proteins (40 µg) were separated 13 
using SDS-PAGE on a 10% polyacrylamide gel and then transferred to Immobilon-P 14 
membranes (Millipore, Billerica, MA). After blocking with Block Ace (Snow Brand 15 
Milk Products, Tokyo, Japan) for 1 hour, the membranes were reacted with the 16 
corresponding specific primary antibody (1:1000), followed by the corresponding 17 
HRP-conjugated secondary antibody (1:1000). The blots were developed using ECL 18 
Western blotting detection reagents. The intensity of each band was analyzed using 19 
Scion Image. 20 
 21 
Clinical chemistry 22 
The collected blood samples were used for clinical chemistry measurements of 23 
leptin (Quantikine Mouse leptin, ELISA/Assay Kit, R&D Systems Inc.), insulin (Insulin 24 
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measurement kit, Morinaga Institute of Biological Science), and insulin-like growth 1 
factor (IGF)-1 (Quantikine Mouse IGF-1, ELISA/Assay Kit, R&D Systems Inc.). The 2 
samples were used without dilution for insulin measurements, while they were diluted 3 
20- and 500-fold for leptin and IGF-1.  4 
 5 
Statistical analysis 6 
Data were analyzed using Student’s t-test (two-sided) when appropriate, with P < 7 




General observations of mice 12 
Food intake was significantly (P < 0.05) lower in group 4 as compared to group 1 13 
(Figure 1A). The mean body weights of mice in groups 2 through 4 are higher than 14 
group 1, though the differences did not reach statistical significance (Figure 1B). In 15 
addition, the AOM and/or DSS treatment led to notable increases in mean relative 16 
epididymal fat pad weight (g/100 g body weight), which was most notable in group 4 17 
(AOM and DSS), as the weight was significantly (P < 0.05) increased by 1.7-fold as 18 
compared to group 1 (Figure 1C). However, the mean relative mesenteric fat weight 19 
(g/100 g body weight) did not significantly differ among the groups (Figure 1D). 20 
 21 
Leptin level in the serum and epididymal fat pad 22 
   As shown in Figure 2, the serum concentration of leptin in group 4 was significantly 23 
(P < 0.05) elevated by 3.0-fold as compared to group 1, which is consistent with our 24 
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previous findings [9]. The serum leptin levels in groups 2 and 3 were also increased by 1 
1.8- and 2.2-fold as compared to group 1, respectively, without statistical significance. 2 
Since leptin is produced mainly by WAT, we assessed the level of leptin mRNA and 3 
protein expression in epididymal fat pads. Leptin mRNA expression in the mice treated 4 
with both AOM and DSS (group 4) was increased by 2.0-fold as compared to the 5 
untreated control (Figure 3A), while leptin protein production was also increased by 6 
4.7-fold (P < 0.05) in group 4 mice (Figure 3B).   7 
 8 
Activation of insulin signaling pathway in epididymal fat pads 9 
   Insulin is an important physiological factor that activates mammalian target of 10 
rapamycin (mTOR), which is a master regulator of protein synthesis [10], adipose tissue 11 
morphogenesis [11], and leptin synthesis/secretion [12] in adipocytes. To determine 12 
whether the insulin signaling pathway was activated in the epididymal fat pads of the 13 
present ICR mice, we ditermined the phosphorylation status of Akt, S6, MEK1/2, and 14 
ERK1/2, all of which are involved in that pathway [13]. As shown in Figure 3, AOM 15 
and DSS treatment substantially increased the phosphorylation of Akt (3.5-fold, P < 16 
0.05, Figure 3C), S6 (38-fold, P < 0.05, Figure 3D), MEK (5.4-fold, P < 0.05, Figure 17 
3E), and ERK (8.8-fold, P < 0.05, Figure 3F), respectively, as compared to the untreated 18 
control mice.  19 
 20 
Serum levels of insulin and IGF-1 21 
   We also assessed the serum levels of insulin and IGF-1 at two time-points, week 2 22 
(just after the cessation of the DSS treatment) and 20 (the termination of the study). As 23 
shown in Figure 4A, serum insulin was elevated in a time-dependent manner by 2.1- 24 
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and 7.8-fold in groups 1 and 4, respectively. Meanwhile, the level of IGF-1 in group 4 1 
was significantly (P < 0.05) higher at week 20 than that in group 1, which was in 2 
contrast to the findings at week 2 (Figure 4B). 3 
  4 
Discussion  5 
 6 
Colorectal cancer (CRC) is the most serious complication associated with long 7 
standing inflammatory bowel disease (IBD), which includes ulcerative colitis and 8 
Crohn’s disease (CD) [14, 15]. Mesenteric WAT is mainly hypertrophic around the 9 
intestines in IBD patients, with axial polarity of inflammation the mainstay contributor 10 
[16]. To better understand the pathogenesis of IBD-related CRC, one (T.T.) of the 11 
present authors and colleagues developed a novel colitis-related CRC model (a 12 
two-stage mouse colon carcinogenesis model), which were initiated with AOM and 13 
promoted by DSS [17]. In the current study, such sequential treatment significantly 14 
increased serum leptin and epididymal fat pad weight, whereas mesenteric fat was not 15 
altered (Figure 1C and D). The individual potencies were less than their combination, 16 
suggesting that AOM and DSS act additively to increase the concentration of leptin in 17 
serum.  18 
Bendet et al. reported that insulin secretion during a 3-hour oral glucose-tolerance 19 
test was increased and homeostatic model assessment values were decreased in CD 20 
patients [18]. In a later study, Bregenzer et al. found increased insulin resistance and β 21 
cell function in CD patients [19]. Furthermore, it should be noted that the concentration 22 
of serum C-peptide, a stable indicator of steady-state insulin secretion, was reported to 23 
be higher in AOM-treated male rats [20]. Since insulin resistance increases the level of 24 
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serum IGF-1 [21], the increased level of IGF-1 in serum of the present group 4 mice 1 
(Figure 4B) may have been associated with putative insulin resistance caused by 2 
AOM/DSS-induced inflammation with other pathologic conditions, including oxidative 3 
stress.  4 
Under physiological conditions, serum leptin levels are affected by several factors, 5 
and leptin secretion from adipocytes is dominantly dependent on the status of adipocyte 6 
signaling molecules. A previous study showed that both insulin and IGF-1 have been 7 
reported to be important physiological factors activating mTOR. Activation of this 8 
pathway mediates multiple insulin effects, such as stimulation of adipogenesis or 9 
lipogenesis [22], and potentiation of leptin secretion. In the present study, the 10 
insulin/IGF signaling pathway was consistently activated, and leptin induction and 11 
production were promoted in the epididymal fat of mice treated with AOM and DSS 12 
(Figure 3A-F). Thus, it is suggested that these hormones stimulate growth and 13 
differentiation of visceral fat tissue, thereby accelerating leptin production.  14 
In conclusion, we found that higher levels of serum insulin and IGF-1 promote 15 
insulin signaling in epididymal fat, which may lead to increased amounts of visceral fat 16 
tissue and a resulting elevation of serum leptin. These events may play certain critical 17 
roles in the development of CRC. However, further studies are warranted for 18 
understanding the precise mechanisms underlying AOM and DSS-induced adipose 19 




This study was supported in part by a Grant-in-Aid for Cancer Research from the 24 
 Miyamoto 11 
Ministry of Health, Labor and Welfare of Japan (A.M. and T.T.), a Grant-in Aid for 1 
Scientific Research (C) (A.M.), and the Japan Society for the Promotion of Science 2 
Fellows (S.M.). 3 
4 
 Miyamoto 12 
References 1 
 2 
[1] Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J. Friedman, 3 
Positional cloning of the mouse obese gene and its human homologue., Nature 4 
372(6505) (1994) 425-432. 5 
[2] S. Sitaraman, X. Liu, L. Charrier, L. Gu, T. Ziegler, A. Gewirtz, D. Merlin, 6 
Colonic leptin: source of a novel proinflammatory cytokine involved in IBD., FASEB J 7 
18(6) (2004) 696-698. 8 
[3] J. Kolaczynski, J. Ohannesian, R. Considine, C. Marco, J. Caro, Response of 9 
leptin to short-term and prolonged overfeeding in humans., J Clin Endocrinol Metab 10 
81(11) (1996) 4162-4165. 11 
[4] C. Garofalo, E. Surmacz, Leptin and cancer., J Cell Physiol 207(1) (2006) 12 
12-22. 13 
[5] J. Hardwick, G. Van Den Brink, G. Offerhaus, S. Van Deventer, M. 14 
Peppelenbosch, Leptin is a growth factor for colonic epithelial cells., Gastroenterology 15 
121(1) (2001) 79-90. 16 
[6] P. Rouet-Benzineb, T. Aparicio, S. Guilmeau, C. Pouzet, V. Descatoire, M. 17 
Buyse, A. Bado, Leptin counteracts sodium butyrate-induced apoptosis in human colon 18 
cancer HT-29 cells via NF-kappaB signaling., J Biol Chem 279(16) (2004) 19 
16495-16502. 20 
[7] O. Ogunwobi, I. Beales, The anti-apoptotic and growth stimulatory actions of 21 
leptin in human colon cancer cells involves activation of JNK mitogen activated protein 22 
kinase, JAK2 and PI3 kinase/Akt., Int J Colorectal Dis 22(4) (2007) 401-409. 23 
[8] M. Koda, M. Sulkowska, L. Kanczuga-Koda, E. Surmacz, S. Sulkowski, 24 
Overexpression of the obesity hormone leptin in human colorectal cancer., J Clin Pathol 25 
60(8) (2007) 902-906. 26 
[9] S. Miyamoto, Y. Yasui, T. Tanaka, H. Ohigashi, A. Murakami, Suppressive 27 
effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male 28 
ICR mice., Carcinogenesis 29(5) (2008) 1057-1063. 29 
[10] C. Lynch, B. Patson, J. Anthony, A. Vaval, L. Jefferson, T. Vary, Leucine is a 30 
direct-acting nutrient signal that regulates protein synthesis in adipose tissue., Am J 31 
Physiol Endocrinol Metab 283(3) (2002) E503-513. 32 
[11] H. Fox, S. Kimball, L. Jefferson, C. Lynch, Amino acids stimulate 33 
phosphorylation of p70S6k and organization of rat adipocytes into multicellular 34 
clusters., Am J Physiol 274(1 Pt 1) (1998) C206-213. 35 
[12] C. Roh, J. Han, A. Tzatsos, K. Kandror, Nutrient-sensing mTOR-mediated 36 
 Miyamoto 13 
pathway regulates leptin production in isolated rat adipocytes., Am J Physiol Endocrinol 1 
Metab 284(2) (2003) E322-330. 2 
[13] R. Bradley, B. Cheatham, Regulation of ob gene expression and leptin 3 
secretion by insulin and dexamethasone in rat adipocytes., Diabetes 48(2) (1999) 4 
272-278. 5 
[14] J. Eaden, K. Abrams, J. Mayberry, The risk of colorectal cancer in ulcerative 6 
colitis: a meta-analysis., Gut 48(4) (2001) 526-535. 7 
[15] R. van Hogezand, R. Eichhorn, A. Choudry, R. Veenendaal, C. Lamers, 8 
Malignancies in inflammatory bowel disease: fact or fiction?, Scand J Gastroenterol 9 
Suppl(236) (2002) 48-53. 10 
[16] K. Karmiris, I. Koutroubakis, E. Kouroumalis, Leptin, adiponectin, resistin, 11 
and ghrelin--implications for inflammatory bowel disease., Mol Nutr Food Res 52(8) 12 
(2008) 855-866. 13 
[17] T. Tanaka, H. Kohno, R. Suzuki, Y. Yamada, S. Sugie, H. Mori, A novel 14 
inflammation-related mouse colon carcinogenesis model induced by azoxymethane and 15 
dextran sodium sulfate., Cancer Sci 94(11) (2003) 965-973. 16 
[18] N. Bendet, E. Scapa, O. Cohen, O. Bloch, D. Aharoni, Y. Ramot, M. Weiss, A. 17 
Halevi, M. Rapoport, Enhanced glucose-dependent glucagon-like peptide-1 and insulin 18 
secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or 19 
ileal resection., Scand J Gastroenterol 39(7) (2004) 650-656. 20 
[19] N. Bregenzer, A. Hartmann, U. Strauch, J. Schölmerich, T. Andus, L. 21 
Bollheimer, Increased insulin resistance and beta cell activity in patients with Crohn's 22 
disease., Inflamm Bowel Dis 12(1) (2006) 53-56. 23 
[20] R. Xiao, J. Carter, A. Linz, M. Ferguson, T. Badger, F. Simmen, Dietary whey 24 
protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA 25 
abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in 26 
azoxymethane-treated male rats., J Nutr Biochem 17(9) (2006) 626-634. 27 
[21] E. Giovannucci, Nutrition, insulin, insulin-like growth factors and cancer., 28 
Horm Metab Res 35(11-12) (2003) 694-704. 29 
[22] H. Cho, J. Park, H. Lee, Y. Lee, J. Kim, Regulation of adipocyte differentiation 30 





 Miyamoto 14 
Figure legends 1 
 2 
Figure 1. The mean food intake (A) by the mice during the study, body (B), epididymal 3 
fat pad (C), and mesenteric fat (D) weights. The weights were measured at the 4 
end of the study.  5 
 6 
Figure 2. Serum leptin levels of all groups. The levels were quantified by ELISA, as 7 
described in Materials and Methods. Each values is shown as the mean ± SD 8 
(n=15). Statistical analysis was performed using Student’s t-test: *P < 0.05 vs. 9 
the untreated control (group 1). 10 
 11 
Figure 3. Leptin production and activation of insulin signaling pathway in epididymal 12 
fat pads at the end of the study. (A) Leptin mRNA expression was determined by 13 
RT-PCR, as described in Materials and Methods, with the levels corrected by 14 
those of GAPDH. Each values is shown as the mean ± SD (n=5), with 3 15 
representative results presented. (B) Leptin protein amounts were quantified by 16 
ELISA, as described in Materials and Methods. Each values is shown as the 17 
mean ± SD (n=10). (C-F) Activation of the insulin signaling pathway was 18 
examined by Western blotting, as described in Materials and Methods. Each 19 
values is shown as the mean ± SD (n=10), with 3 representative results 20 
presented. Statistical analysis was performed using Student’s t-test: *P < 0.05 vs. 21 
the untretated control (group 1). 22 
 23 
Figure 4. Levels of serum insulin (A) and IGF-1 (B) after weeks 2 and 20. Serum 24 
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insulin and IGF-1 levels were quantified by ELISA, as described in Materials 1 
and Methods. Open bars; at week 2, closed bars; at week 20. Each values is 2 
shown as the mean ± SD (n=5 or 15). Statistical analysis was performed using 3 
Student’s t-test: *P < 0.05 vs. the untreated control (group 1) for the 4 
























































































































































































































Fig. 4 (Miyamoto et al.)
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